17-7222175-A-G
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PS1PVS1_ModeratePM2_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_000018.4(ACADVL):c.753-2A>G variant in ACADVL occurs within the canonical splice acceptor site (-2) of intron 8. It is predicted to cause skipping of biologically-relevant-exon 9/20, resulting in an in-frame deletion (removes amino acids Ser-His) that is predicted to escape nonsense mediated decay and remove <10% of the protein (PVS1_Moderate; PMIDs 9973285, 11590124). However, a different nucleotide change at the same position within the canonical splice acceptor site of intron 8 [c.753-2A>C; ClinVar ID: 92290] is classified as likely pathogenic for very long chain acyl CoA dehydrogenase (VLCAD) deficiency by the ClinGen ACADVL Variant Curation Expert Panel (PS1). At least one individual with this variant was identified by newborn screen, but this information is insufficient for to use toward classification (PMID:26385305). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). Due to conflicting evidence, this variant is classified as a variant of uncertain significance for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PS1, PVS1_Moderate, PM2_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA397723611/MONDO:0008723/021
Frequency
Consequence
NM_000018.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461866Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727238
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Very long chain acyl-CoA dehydrogenase deficiency Pathogenic:3
- -
The NM_000018.3:c.753-2A>G (NP_000009.1:p.?) [GRCH38: NC_000017.11:g.7222175A>G] variant in ACADVL gene is interpretated to be Pathogenic based on ACMG guidelines (PMID: 25741868). This variant has been reported. This variant meets the following evidence codes reported in the ACMG guidelines: PVS1, PS3 -
The NM_000018.4(ACADVL):c.753-2A>G variant in ACADVL occurs within the canonical splice acceptor site (-2) of intron 8. It is predicted to cause skipping of biologically-relevant-exon 9/20, resulting in an in-frame deletion (removes amino acids Ser-His) that is predicted to escape nonsense mediated decay and remove <10% of the protein (PVS1_Moderate; PMIDs 9973285, 11590124). However, a different nucleotide change at the same position within the canonical splice acceptor site of intron 8 [c.753-2A>C; ClinVar ID: 92290] is classified as likely pathogenic for very long chain acyl CoA dehydrogenase (VLCAD) deficiency by the ClinGen ACADVL Variant Curation Expert Panel (PS1). At least one individual with this variant was identified by newborn screen, but this information is insufficient for to use toward classification (PMID: 26385305). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). Due to conflicting evidence, this variant is classified as a variant of uncertain significance for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PS1, PVS1_Moderate, PM2_Supporting. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at